In this episode, we explore the puzzling connection between clozapine and obsessive-compulsive symptoms in schizophrenia patients. Does this wonder drug actually cause OCD, or are we missing a deeper story about how protective behaviors transform into compulsive habits?

Faculty: Oliver Freudenreich, M.D. Host: Richard Seeber, M.D.

• Learn more about our membership here
• Earn 0.5 CME: Quick Take Vol. 70
• Clozapine and OCD-Like Symptoms: What's the Connection?

In this episode, we explore groundbreaking head-to-head research comparing topiramate and naltrexone for alcohol use disorder, revealing surprising equivalence in effectiveness. Could the off-label option actually be as good as our FDA-approved standard for treating problematic drinking?

Faculty: David Gorelick, M.D. Host: Richard Seeber, M.D.

• Learn more about our membership here
• Earn 0.5 CME: Quick Take Vol. 69
• Can Topiramate Replace FDA-Approved Medications for Alcohol Use Disorder?

In this episode, we discuss the critical challenges of benzodiazepine discontinuation, exploring Benzodiazepine-Induced Neurological Dysfunction (BIND) and effective support strategies for patients experiencing protracted withdrawal. What can clinicians do when over 50% of patients report finding more help from online forums than from medical professionals?

Faculty: Alexis Ritvo, M.D. Host: Richard Seeber, M.D.

• Learn more about our memberships here
• Earn 1.25 CME: Strategies for Successful Benzodiazepine Deprescribing
• Beyond Benzodiazepine Discontinuation: Understanding Life Effects and Support Strategies

In this episode, we explore the potentially fatal side effects of clozapine that often receive less attention than agranulocytosis: bowel obstruction and pneumonia. Could your vigilant monitoring of blood counts be overshadowing equally dangerous risks?

Faculty: Oliver Freudenreich, M.D. Host: Richard Seeber, M.D.

• Learn more about our membership here
• Earn 0.5 CME: Quick Take Vol. 69
• Clozapine: The Hidden Risks of Ileus and Pneumonia

In this episode, we discuss evidence-based strategies for safely tapering patients off benzodiazepines, including cut-and-hold and microtapering techniques. What's the best approach when commercial dosage forms limit gradual reductions?

Faculty: Alexis Ritvo Host: Richard Seeber, M.D.

• Learn more about our memberships here
• Earn 1.25 CME: Strategies for Successful Benzodiazepine Deprescribing
• Techniques for Successful Benzodiazepine Tapering

In this episode, we explore lithium's surprising positive effect on bone mineral density in patients with bipolar disorder. Could the medication many psychiatrists use as a mood stabilizer also be protecting patients from osteoporosis?

Faculty: Paul Zarkowski, M.D. Host: Richard Seeber, M.D.

• Learn more about our membership here
• Earn 0.5 CME: Quick Take Vol. 68
• Can Lithium Protect Against Osteoporosis?

In this episode, we explore evidence-based strategies for successful benzodiazepine tapering with addiction psychiatrist Dr. Alexis Ritvo. How can clinicians minimize withdrawal effects while supporting patients through this challenging process?

Faculty: Alexis Ritvo, M.D. Host: Richard Seeber, M.D.

• Learn more about our membership here
• Earn 1.25 CMEs: Strategies for Successful Benzodiazepine Deprescribing
• Understanding the Principles of Benzodiazepine Tapering

In this episode, we explore compelling evidence from the UK Biobank showing how vitamin D deficiency may increase dementia risk by up to 25%. Could this affordable supplement be an essential piece of your brain health strategy?

Faculty: Scott Beach, M.D. Host: Richard Seeber, M.D.

• Learn more about our membership here
• Earn 0.5 CME: Quick Take Vol. 68
• Can Vitamin D Deficiency Increase the Risk of Alzheimer's Disease?

In this episode, we explore the complex process of benzodiazepine deprescribing, examining when and how to help patients reduce or discontinue these medications. How can clinicians balance the benefits of deprescription against the challenges of withdrawal?

Faculty: Alexis Ritvo, M.D. Host: Richard Seeber, M.D.

• Learn more about our memberships here
• Earn 1.25 CMEs: Strategies for Successful Benzodiazepine Deprescribing
• Benzodiazepine Deprescription: Indications, Benefits, and Risks

In this episode, we explore the unique considerations for using long-acting injectable antipsychotics in women with schizophrenia. How might hormonal fluctuations throughout a woman's life impact treatment decisions for schizophrenia?

Faculty: Oliver Freudenreich, M.D. Host: Richard Seeber, M.D.

• Learn more about our membership here
• Earn 0.5 CME: Quick Take Vol. 68
• Long-Acting Antipsychotics: An Option for Women with Schizophrenia?